Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 77KA5 | — |
due to difficulty expelling the air bubble possibility that approximately 150 patients received incomplete doses; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete dose administered in an unspecified number of patients who received Men B NVS (Bexsero) (batch number 77KA5, expiry date 30-NOV-2027) and (batch number 3L339, expiry date 30-SEP-2027) for prophylaxis. On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incomplete dose administered (Verbatim: due to difficulty expelling the air bubble possibility that approximately 150 patients received incomplete doses). The outcome of the incomplete dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 14-MAY-2025 Nurse called and inform that due to difficulty expelling the air bubble of Bexsero Prefilled Syringe there was a possibility that approximately 150 patients received incomplete doses during the last 3 months. Reporter was not sure of the total amount of patients and the dates of administration.